Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesJack Nathan Medical Corp

Jack Nathan Medical Corp

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
0.01 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
0.87M

Momentum Score

…

Jack Nathan Medical Corp., together with its subsidiaries, designs, builds, and operates medical clinics in Canada and Mexico. It operates Jack Nathan MedSpa, a aesthetic wellness platform that provides aesthetic and wellness services, including injectables, skin rejuvenation, laser treatments and therapies, skin care therapies, and wellness treatments. In addition, the company's platform also supports primary care, virtual care, and a range of allied health services, such as physiotherapy, chiropractic, skincare, and wellness. The company was founded in 2006 and is headquartered in Woodbridge, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Jack Nathan Medical Corp (TSX‑V: JNH) is limited; it is a small‑cap company in the medical/healthcare sector. Long-term growth may be supported by expanding distribution, adoption by healthcare providers and demographic trends; investors may find exposure to niche medical-device commercialization appealing.

Key investment risks include limited public disclosure, small operating scale with thin liquidity, need for additional financing, regulatory approval uncertainty and dependence on a narrow product or customer base.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
-6.71M
Revenue Per Share
-0.08
Gross Profit TTM
-5.42M
Debt / Equity
-
ROE
-1961.56%
Net Debt
2.33M
ROCE
-562.11%
Diluted EPS TTM
-0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2023-01-31 2022-12-31 2022-01-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2023-01-31 2022-12-31 2022-01-31 2021-12-31
Income before tax -6.64M -6.99M -6.99M -8.23M -8.23M
Minority interest 0.00M 0.00M 0.00M 0.21M 0.21M
Net income - -7.08M -7.08M -7.81M -7.81M
Selling general administrative - 15.82M 15.82M 12.81M 12.81M
Gross profit 12.86M 11.82M 11.82M 6.92M 6.92M
Reconciled depreciation - 1.07M 1.07M 0.52M 0.52M
Ebit - -5.20M -5.20M -6.55M -6.55M
Ebitda - -5.51M -5.51M -7.54M -7.54M
Operating income -4.72M -5.31M -5.31M -6.94M -6.94M
Interest expense - 0.41M 0.41M 0.18M 0.18M
Tax provision - -0.09M -0.09M -0.22M -0.22M
Interest income - 0.01M 0.01M 0.04M 0.04M
Net interest income - -0.40M -0.40M -0.15M -0.15M
Income tax expense - -0.09M -0.09M -0.22M -0.22M
Total revenue 17.42M 15.49M 15.49M 9.64M 9.64M
Total operating expenses 21.48M 20.79M 20.79M 16.58M 16.58M
Cost of revenue 4.56M 3.67M 3.67M 2.71M 2.71M
Total other income expense net -1.56M -1.44M -1.44M -1.14M -1.14M
Net income from continuing ops - -6.90M -6.90M -8.02M -8.02M
Net income applicable to common shares - -6.90M -6.90M -7.81M -7.81M
Breakdown 2023-01-31 2022-12-31 2022-01-31 2021-12-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-12-31 2022-01-31 2021-12-31 2021-01-31
Total assets 6.45M 6.45M 8.14M 8.14M 10.65M
Intangible assets 1.29M 1.29M 2.18M 2.18M 0.56M
Other current assets - - - - -0.00M
Total liab 8.32M 8.32M 4.06M 4.06M 2.13M
Total stockholder equity -1.87M -1.87M 4.08M 4.08M 8.53M
Other current liab - - 0.37M 0.37M 0.02M
Common stock 19.77M 19.77M 19.64M 19.64M 18.53M
Capital stock 19.77M 19.77M 19.64M 19.64M 18.53M
Retained earnings -25.92M -25.92M -19.02M -19.02M -10.99M
Other liab 0.60M 0.60M 0.71M 0.71M 0.70M
Good will 0.00M 0.00M 1.01M 1.01M 0.60M
Other assets 0.09M 0.09M 0.10M 0.10M 0.11M
Cash 1.46M 1.46M 1.06M 1.06M 7.69M
Total current liabilities 5.61M 5.61M 2.70M 2.70M 0.96M
Net debt 2.33M 2.33M - - -
Short long term debt 2.13M 2.13M 0.20M 0.20M 0.21M
Other stockholder equity -0.11M -0.11M 0.14M 0.14M 0.15M
Property plant equipment 2.56M 2.56M 2.61M 2.61M 1.23M
Total current assets 2.51M 2.51M 2.24M 2.24M 8.15M
Net tangible assets -3.16M -3.16M 0.89M 0.89M 7.37M
Net receivables 0.83M 0.89M 0.83M 0.88M 0.16M
Long term debt 1.67M 1.67M 0.11M 0.11M 0.18M
Accounts payable 3.15M 3.15M 1.80M 1.80M 0.72M
Non current assets total 3.94M 3.94M 5.90M 5.90M 2.50M
Capital lease obligations 0.76M 0.76M 0.85M 0.85M 0.32M
Breakdown 2023-12-31 2023-01-31 2022-12-31 2022-01-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2023-01-31 2022-12-31 2022-01-31 2021-12-31
Investments -4.50M -2.69M -2.69M -2.14M -2.14M
Change to liabilities - 1.28M 1.28M 0.88M 0.88M
Total cashflows from investing activities - -2.76M -2.76M -2.14M -2.14M
Net borrowings - -0.59M -0.59M -0.26M -0.26M
Total cash from financing activities 12.66M 5.35M 5.35M -0.16M -0.16M
Change to operating activities - 0.10M 0.10M -0.18M -0.18M
Net income - -6.90M -6.90M -7.81M -7.81M
Change in cash 6.43M 0.40M 0.40M -6.62M -6.62M
Begin period cash flow 0.82M 1.06M 1.06M 7.69M 7.69M
End period cash flow - 1.46M 1.46M 1.06M 1.06M
Total cash from operating activities - -2.00M -2.00M -4.34M -4.34M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 1.20M 1.07M 1.07M 0.52M 0.52M
Change to account receivables -0.30M 0.00M 0.00M -0.67M -0.67M
Other cashflows from financing activities - 2.20M 2.20M 2.20M 2.20M
Change to netincome - 2.45M 2.45M 2.92M 2.92M
Capital expenditures 3.93M 2.59M 2.59M 0.95M 0.95M
Change in working capital 0.74M 1.38M 1.38M 0.03M 0.03M
Stock based compensation - 1.13M 1.13M 2.50M 2.50M
Other non cash items -0.87M -0.08M -0.08M -0.33M -0.33M
Free cash flow -8.92M -4.59M -4.59M -5.29M -5.29M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
JNH
Jack Nathan Medical Corp		 -
-%		 0.01 - - 0.25 7.84 0.64 -1.92
NPTH
NeuPath Health Inc		 -
-%		 0.54 - 7.75 0.39 1.69 0.50 13.93
NLH
Nova Leap Health Corp		 -0.01
2.08%		 0.47 - 20.49 1.08 1.30 0.83 24.88
KDA
KDA Group Inc		 0.01
10.00%		 0.06 - - 72.57 2.93 85.92 23.03
ELM
Element Lifestyle Retirement Inc		 -
-%		 0.01 - - 0.63 174.48 2.12 11.33

Profile*

Jack Nathan Medical Corp

Jack Nathan Medical Corp., together with its subsidiaries, designs, builds, and operates medical clinics in Canada and Mexico. It operates Jack Nathan MedSpa, a aesthetic wellness platform that provides aesthetic and wellness services, including injectables, skin rejuvenation, laser treatments and therapies, skin care therapies, and wellness treatments. In addition, the company's platform also supports primary care, virtual care, and a range of allied health services, such as physiotherapy, chiropractic, skincare, and wellness. The company was founded in 2006 and is headquartered in Woodbridge, Canada.

6-6150 Highway 7, Woodbridge, ON, Canada

416 637 2240

https://www.jacknathanhealth.com

Name Title Year Born
Dr. Glenn Copeland CEO, Pres & Chief Medical Officer NA
Mr. Michael Marchelletta Co-Founder & Exec. Vice-Chairman NA
Mr. Spence Walker C.A., CPA Interim Chief Financial Officer 1958
Ms. Marcy Herriman Chief Operating Officer NA
Mr. Serge Cinelli Chief Technology Officer NA
Jennifer Usher Director of Marketing & Communications NA
Mr. David Berman Sec. NA
Dr. Glenn Copeland CEO, President, Chief Medical Officer & Director NA
Mr. Michael Marchelletta Co-Founder & Executive Vice-Chairman NA
Dr. Glenn Copeland CEO, President, Chief Medical Officer & Chairman NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 29.99
+13.13%
AP-UN
CAD 4.19
+12.94%
ARTG
CAD 39.66
+12.93%
BZ
CAD 4.14
+10.99%
FFH
CAD 2759.48
+10.87%
DRUG
CAD 27.12
-26.86%
HUT
CAD 69.10
-22.27%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.85
-14.43%
MOON
CAD 4.09
-12.79%

Equity Sectors*

  • Basic Materials

    +3.69%

  • Communication Services

    +2.61%

  • Consumer Cyclical

    +2.96%

  • Consumer Defensive

    +1.11%

  • Energy

    -5.01%

  • Financial Services

    +2.20%

  • Healthcare

    -0.56%

  • Industrials

    -0.73%

  • Real Estate

    +1.90%

  • Technology

    +0.05%

  • Utilities

    +1.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…